News

Hikma buys rights to FDA-approved cancer treatment trametinib, a generic version of Novartis' (NVS) Mekinist, with 180 days ...
European drugmaker Novartis (NVS), best known for blockbuster drugs like Entresto, Cosentyx, and Kesimpta, just announced a major U.S.
New Housing Price Index (March) The national index edged up 0.1% on a month-over-month basis in February, following a decline in the previous month. Cargojet Inc. (T.CJT) (Q1) EPS of $1.09 compared to ...
Entrepreneurial CMO 50 list recognizes fifty chief marketers whose approach to driving growth is charting new paths.
I was at Novartis headquarters in Basel yesterday for the company’s Q4 results, and my burning question was – did the company have any designs on entering the viral vector-based gene therapy ...
Scholar Rock Holding Corporation's apitegromab shows promise for SMA treatment, aims for 2025 launch. Click for my updated ...
Vas Narasimhan is global head of drug development and chief medical officer at Novartis, and spoke to pharmaphorum at the company’s recent Q4 results conference. He says numerous pilot studies ...
Stifel head of biotech research Paul Matteis suggests looking for biotech names not dependent on the FDA while this sector ...
USA News Group News Commentary – Routine medical appointments or cancer screening rates—an important aspect in increasing ...
We recently published a list of the 13 Best Biotech Penny Stocks to Buy According to Hedge Funds. In this article, we are ...